Pharmacy Benefit Managers (PBMs)

Arkansas Gov. Sanders Doubles Down on Law Barring PBMs from Owning Pharmacies

Arkansas Gov. Sarah Huckabee Sanders said her administration is not deterred on the state’s new law governing pharmacy benefit managers despite legal challenges from two of the industry’s “Big Three.” In an interview with the Daily Wire, Sanders took aim at CVS Health in particular, saying that closing stores in Arkansas proves its priorities are […]

Arkansas Gov. Sanders Doubles Down on Law Barring PBMs from Owning Pharmacies Read More »

CVS and Express Scripts Sue Arkansas over Restriction on Pharmacy Benefit Managers

CVS and Express Scripts asked a federal judge on Thursday to block a law prohibiting pharmacy benefit managers from owning or operating pharmacies in Arkansas, challenging the first such restriction enacted by a state. The lawsuits come a little over a month after Gov. Sarah Huckabee Sanders signed the legislation restricting pharmacy benefit managers, also

CVS and Express Scripts Sue Arkansas over Restriction on Pharmacy Benefit Managers Read More »

PBM Limits Could Finally Pass, If Congress Moves Its Tax-Cut Bill

Long-sought legislation to monitor and restrict how pharmacy benefit mangers operate could finally pass — if Republicans can move their sweeping budget bill that includes a string of those provisions. New PBM measures are tucked into the bill advanced Wednesday by the House Energy and Commerce Committee, which aims to cut more than $880 billion

PBM Limits Could Finally Pass, If Congress Moves Its Tax-Cut Bill Read More »

California Seeks to Further Regulate PBMs

On May 14, California Gov. Gavin Newsom proposed additional state oversight on pharmacy benefit managers, which negotiate drug prices between payers and drugmakers. In a revised 2025-2026 budget, the governor penned several oversight strategies regarding PBMs, according to a news release. The proposal would allow the state’s Department of Managed Health Care to regulate PBMs

California Seeks to Further Regulate PBMs Read More »

Drugmakers Have Spent Millions Targeting ‘Middlemen’—and It’s Paying Off

When President Trump signed an executive order this month to try to reduce drug prices, the pharmaceutical industry scored a big win. Within 90 days, the order said, Trump’s staff should put together a report “re-evaluating the role of middlemen,” who have been the target of one of the most sweeping and expensive lobbying campaigns

Drugmakers Have Spent Millions Targeting ‘Middlemen’—and It’s Paying Off Read More »

Scroll to Top